#None #Healthcare Automation #Infection Control #Disease Prevention

Growth of the Infection Control Market

The infection control market is experiencing an impressive rise, with projections indicating an increase from USD 58.5 billion in 2026 to USD 80.2 billion by 2031. This translates to a compound annual growth rate (CAGR) of 6.5%. Understanding the factors driving this growth involves diving into the healthcare landscape, specifically in hospitals and healthcare facilities where infection prevention is paramount.

The Landscape of Infection Control

The critical nature of infection control can be seen in data from the U.S. Centers for Disease Control and Prevention (CDC), which estimates that on any given day, 1 in 31 hospital patients suffers from a healthcare-associated infection (HAI). In 2023 alone, around 518,000 such infections were reported in U.S. acute-care hospitals. Continuous efforts in infection prevention have been successful in areas like central line-associated bloodstream infections, catheter-associated urinary tract infections, and C. difficile infections, which saw reductions of 9%, 10%, and 11%, respectively. However, some complications, such as surgical-site infections, indicate that vigilance is still required.

Internationally, the situation reflects wider gaps in readiness. According to WHO reports, only 15.8% of healthcare facilities met the essential standards for infection prevention and control. The demand for sterile environments is further exacerbated by the absence of proper hygiene services in many regions.

Automation Propelling Change

A noteworthy factor influencing the growth in the infection control market is the trend towards automation in reprocessing medical instruments. Reprocessing includes cleaning, disinfecting, and sterilizing reusable medical devices, which can often be a labor-intensive and error-prone task. To address these challenges, automated washer-disinfectors and low-temperature sterilization methods are becoming prevalent.

For example, innovations like Getinge's Aquadis Endo 110 automated endoscope reprocessor, launched in June 2026, enhance throughput by as much as 36%. Such advancements streamline processes, improve efficiency, and ensure consistent results in health facilities.

Shifts Towards Monitoring and Hygiene Solutions

As infection control practices mature, hospitals increasingly focus on verifying their cleaning processes. Improved systems for infection surveillance have been instituted across many healthcare institutions globally. WHO reported that 78% of the surveyed secondary and tertiary healthcare organizations have monitoring systems in place for infection prevention and control. Technology providers are capitalizing on this shift, offering solutions that equip hospitals with tools to demonstrate their compliance with hygiene standards.

Ecolab's environmental hygiene monitoring system and Solventum's sterilization assurance portfolio are examples of the evolving landscape where service-based solutions are becoming as important as products themselves. This insight underscores a broader recognition of hygiene’s role within pharmaceuticals, food production, and health services.

Market Drivers

The growing prevalence of HAIs significantly impacts healthcare institutions' operational protocols, prompting the need for improved sterilization methods. Other catalysts for the market's growth include:

• - Reprocessing Demand: The necessity for repeated cleaning and sterilization of surgical tools and medical devices leads to high demand for advanced reprocessing equipment and consumables.
• - Invasive Procedures: With more surgeries involving instruments in sterile areas, the need for efficient sterilization systems becomes critical for compliance and patient safety.
• - Antimicrobial Resistance: Increasing attention on the relationship between infections and antimicrobial resistance has led to heightened focus on sterilization and disinfection.
• - Regulatory Compliance: Stricter clinical guidelines necessitate hospitals to implement appropriate sterilization and disinfection protocols.

Moreover, the demand for infection control solutions extends beyond hospitals to pharmaceutical companies, diagnostic labs, and outpatient centers, ensuring a wide market potential.

Challenges Ahead

Despite the growth prospects, the infection control market faces challenges. Many medical devices have complicated designs that make them difficult to clean effectively. Cleaning and sterilization protocols must be rigorously validated, and suppliers are challenged to demonstrate that their products perform consistently. Additionally, considerations concerning costs, infrastructure, and staff training present barriers that players within this market must navigate.

Recent Developments

Significant acquisitions and investments have marked the landscape recently. For instance, in October 2026, STERIS plc announced its intention to acquire Xodus Medical, thereby expanding its infection control offerings. Concurrently, Reckitt Benckiser also announced substantial investments aimed at enhancing its disinfection and hygiene innovation capabilities. These moves demonstrate a commitment to advancing infection control technologies and services.

Conclusion

As the infection control market evolves, automating processes, improving hygiene standards, and developing rigorous monitoring systems are key strategies that will drive future growth. Ensuring compliance with evolving regulations and adapting to market demands will be essential for companies operating in this critical sector. The next few years appear promising for investors and stakeholders eager to contribute to safer healthcare environments.